Eagle Bay Advisors’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-210
| Closed | -$2.11K | – | 1007 |
|
|
2023
Q4 | $2.11K | Hold |
210
| – | – | ﹤0.01% | 736 |
|
|
2023
Q3 | $605 | Hold |
210
| – | – | ﹤0.01% | 814 |
|
|
2023
Q2 | $800 | Hold |
210
| – | – | ﹤0.01% | 806 |
|
|
2023
Q1 | $391 | Hold |
210
| – | – | ﹤0.01% | 878 |
|
|
2022
Q4 | $483 | Hold |
210
| – | – | ﹤0.01% | 870 |
|
|
2022
Q3 | $1K | Hold |
210
| – | – | ﹤0.01% | 888 |
|
|
2022
Q2 | $1.16K | Buy |
+210
| New | +$1.16K | ﹤0.01% | 841 |
|
|
2022
Q1 | – | Sell |
-160
| Closed | -$1K | – | 1012 |
|
|
2021
Q4 | $1K | Hold |
160
| – | – | ﹤0.01% | 1044 |
|
|
2021
Q3 | $2K | Hold |
160
| – | – | ﹤0.01% | 959 |
|
|
2021
Q2 | $3K | Buy |
+160
| New | +$3K | ﹤0.01% | 809 |
|